COR Stock: Price, Earnings History and SEC Filings
Cencora, Inc. (COR) last traded at $330.84, up 0.09% on the latest session and up 10.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $4.48 against an analyst estimate of $4.37, a beat of 2.5%.
$330.84 +0.09%
1 month+10.19%
52-week high$377.54
52-week low$244.82
Volume1.35M
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
COR earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $4.48 | $4.37 | +2.52% |
| Mar 2026 | May 6, 2026 | $4.75 | $4.80 | -1.04% |
| Dec 2025 | Feb 4, 2026 | $4.08 | $4.07 | +0.25% |
| Sep 2025 | Nov 5, 2025 | $3.84 | $3.79 | +1.32% |
COR beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for COR
SEC filing data is not available right now. You can search for COR on SEC EDGAR.
COR news
- Cencora (COR) Stock Still Looks Undervalued After Its 173% RunNov 1, 2026 · finance.yahoo.com
- Is Cencora (COR) Fully Valued Following Its $2.4b American Oncology Network Deal?Nov 1, 2026 · finance.yahoo.com
- What Does Cencora (COR) Gain From Expanding Into 12 More States?Oct 31, 2026 · finance.yahoo.com
- 2 large-cap stocks with impressive fundamentals and 1 we ignoreOct 30, 2026 · finance.yahoo.com
- Cencora Gears Up to Report Q4 Results: How to Play the Stock?Oct 30, 2026 · finance.yahoo.com
- Unveiling Cencora (COR) Q4 Outlook: Wall Street Estimates for Key MetricsOct 30, 2026 · finance.yahoo.com
- Is Buying McKesson Stock Near Its High A Bad Idea?Oct 30, 2026 · trefis.com
- Is It A Mistake To Buy Cardinal Health Stock At A High?Oct 29, 2026 · trefis.com
About Cencora, Inc.
Cencora, Inc. (COR) is a US-listed public company on NYSE.